Clinical trial Recruiting at 1 site Interventional Ages 55 and up

Mind-body and walking program for older adults with chronic pain

Official title: Randomized, Hybrid Type 1 Effectiveness-implementation Trial of GetActive+ vs Treatment as Usual; iHOPE Study

Run by Massachusetts General Hospital · NCT06119698 · Data updated 2026-11-12

This study tests if a 10-week mind-body and walking program can help older adults with chronic pain feel better compared to their usual treatment.

Quick facts

Study typeInterventional
Ages55 Years and up
SexAll
Enrollment200 (estimated)
SponsorMassachusetts General Hospital
Academic / other
Locations1 site (Boston, Massachusetts)
StatusRecruiting
StartedOctober 1, 2024
Main results expectedApril 1, 2027
Study endsJuly 2027
Registry record updatedNovember 18, 2025
Trial IDNCT06119698 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are older adults aged 55 and above with a diagnosis of musculoskeletal chronic pain and a moderate pain score.

Probably not a fit

Patients with serious medical illnesses expected to worsen, or those with untreated psychotic or substance use disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project aims to evaluate the effectiveness and implementation of a 10-week mind-body and walking program called GetActive+ compared to treatment as usual for older adults with chronic pain. The study will involve 200 participants who will be assessed on their physical and emotional function through self-reported measures, performance-based tests, and objective step counts at multiple time points. The program incorporates skills such as goal setting, pacing, and mind-body techniques to enhance physical activity and overall well-being. Data will be collected at baseline, post-intervention, and at a 6-month follow-up to determine the program's feasibility and acceptability.

Why it matters

Potential benefit: If successful, this program could significantly improve physical and emotional well-being for older adults suffering from chronic pain.

How similar studies have gone: Other studies have shown promise with mind-body interventions for chronic pain, suggesting potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Older Adults (i.e., age \>=55)
2. Diagnosed musculoskeletal chronic pain of any type (e.g., pain \> 3 months)
3. Pain score \>=4 (moderate) on the Numerical Rating Scale
4. Cognitively able to participate as measured by the Short Portable Mental Health questionnaires (e.g., \<4 errors)
5. Self-reported ability to complete the 6-minute walk test including with assistive devices
6. Patient at Revere HealthCare Center or MGH Broadway Primary Care in Revere who is cleared for participation by medical staff
7. English or Spanish fluency and literacy

Exclusion Criteria:

1. Current serious medical illness that is expected to worsen in the next 6 months (e.g., cancer)
2. Individuals who are unwilling or unable to comply with study procedures including wearing a smartwatch
3. Active suicidal ideation with plan or intent
4. Active and untreated serious mental health or substance use disorder

Where it's running

  • Massachusetts General Hospital
    Boston, Massachusetts, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.